(Q36618155)

15 August 2017

Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results (English)

1 reference

15 August 2017

1 reference

M Raderer

1

1 reference

15 August 2017

G Hamilton

2

1 reference

15 August 2017

A Kurtaran

3

1 reference

15 August 2017

J Valencak

4

1 reference

15 August 2017

I Haberl

5

1 reference

15 August 2017

O Hoffmann

6

1 reference

15 August 2017

G V Kornek

7

1 reference

15 August 2017

F Vorbeck

8

1 reference

15 August 2017

M H Hejna

9

1 reference

15 August 2017

I Virgolini

10

1 reference

15 August 2017

W Scheithauer

11

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

3-4

1 reference

15 August 2017

535-537

1 reference

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Molecular pharmacology of somatostatin receptors.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Somatostatin Analogue Phase I Trials in Neuroendocrine Neoplasms

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362412

Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas

20 September 2018

1 reference

12 December 2020

1 reference

12 December 2020

Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro

1 reference

12 December 2020

Treatment of adenocarcinoma of the pancreas with somatostatin and gonadoliberin (luteinizing hormone-releasing hormone). The French Associations for Surgical Research

1 reference

12 December 2020

Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160

1 reference

12 December 2020

Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors

1 reference

12 December 2020

High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction?

1 reference

12 December 2020

Intramuscular injections of slow-release lanreotide (BIM 23014) in acromegalic patients previously treated with continuous subcutaneous infusion of octreotide (SMS 201-995)

1 reference

12 December 2020

A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients

1 reference

12 December 2020

A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690084

7 January 2021

Role of octreotide in the treatment of pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690084

7 January 2021

Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690084

7 January 2021

Somatostatin receptors in malignant tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690084

7 January 2021

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690084

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690084

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

10027326

1 reference